Генетическая карта здоровья Пациент: 1 Полных лет: 36; Рост 158 см; Вес 47 кг; имт=18. 8; Не курит Используемые термины

93. Simpson, A.J., et al., The effects of chronic smoking on the fibrinolytic potential of plasma and platelets. Br J Haematol, 1997. 97(1): p. 208-13.

94. Kruithof, E.K., Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins. Thromb Haemost, 2008. 100(6): p. 969-75.

95. Kohler, H.P. and P.J. Grant, Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med, 2000. 342(24): p. 1792-801.

96. Carmeliet, P., et al., Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation, 1997. 96(9): p. 3180-91.

97. Wiklund, P.G., et al., Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts. Stroke, 2005. 36(8): p. 1661-5.

98. Balta, G., C. Altay, and A. Gurgey, PAI-1 gene 4G/5G genotype: A risk factor for thrombosis in vessels of internal organs. Am J Hematol, 2002. 71(2): p. 89-93.

99. Vergouwen, M.D., et al., Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke, 2004. 35(6): p. 1280-3.

100. Yamada, N., et al., The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia. J Hum Genet, 2000. 45(3): p. 138-41.

101. Cho, S.H., C.H. Ryu, and C.K. Oh, Plasminogen activator inhibitor-1 in the pathogenesis of asthma. Exp Biol Med (Maywood), 2004. 229(2): p. 138-46.

102. Buckova, D., L. Izakovicova Holla, and J. Vacha, Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population. Allergy, 2002. 57(5): p. 446-8.

103. Kowal, K., et al., Analysis of -675 4G/5G SERPINE1 and C-159T CD14 polymorphisms in house dust mite-allergic asthma patients. J Investig Allergol Clin Immunol, 2008. 18(4): p. 284-92.

104. Moshfegh, K., et al., Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet, 1999. 353(9150): p. 351-4.

105. Tsantes, A.E., et al., Lack of association between the platelet glycoprotein Ia C807T gene polymorphism and coronary artery disease: a meta-analysis. Int J Cardiol, 2007. 118(2): p. 189-96.

106. Nikolopoulos, G.K., et al., Integrin, alpha 2 gene C807T polymorphism and risk of ischemic stroke: a meta-analysis. Thromb Res, 2007. 119(4): p. 501-10.

107. Su, G., Z. Wang, and Y. Ding, Association of the platelet membrane glycoprotein I a C807T gene polymorphism with aspirin resistance. J Huazhong Univ Sci Technolog Med Sci, 2007. 27(6): p. 664-7.

108. Maeno, T., et al., The 807T allele in alpha2 integrin is protective against atherosclerotic arterial wall thickening and the occurrence of plaque in patients with type 2 diabetes. Diabetes, 2002. 51(5): p. 1523-8.

109. Kishimoto, T., The biology of interleukin-6. Blood, 1989. 74(1): p. 1-10.

110. Kita, M., et al., Induction of cytokines in human peripheral blood mononuclear cells by mycoplasmas. Microbiol Immunol, 1992. 36(5): p. 507-16.

111. Mysliwska, J., et al., The -174GG interleukin-6 genotype is protective from retinopathy and nephropathy in juvenile onset type 1 diabetes mellitus. Pediatr Res, 2009. 66(3): p. 341-5.

112. Tischendorf, J.J., et al., The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6. Int J Immunogenet, 2007. 34(6): p. 413-8.

113. Kamarainen, O.P., et al., Common interleukin-6 promoter variants associate with the more severe forms of distal interphalangeal osteoarthritis. Arthritis Res Ther, 2008. 10(1): p. R21.

114. Naumova, E., et al., Immunological markers contributing to successful aging in Bulgarians. Exp Gerontol, 2004. 39(4): p. 637-44.

115. Treszl, A., et al., Genetic variants of TNF-[FC12]a, IL-1beta, IL-4 receptor [FC12]a-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants. Biol Neonate, 2003. 83(4): p. 241-5.

116. Schaaf, B.M., et al., Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med, 2003. 168(4): p. 476-80.

117. Moscovis, S.M., et al., Interleukin-10 and sudden infant death syndrome. FEMS Immunol Med Microbiol, 2004. 42(1): p. 130-8.

118. Zedan, M., et al., Gene polymorphisms of tumor necrosis factor alpha-308 and interleukin-10-1082 among asthmatic Egyptian children. Allergy Asthma Proc, 2008. 29(3): p. 268-73.

119. Karjalainen, J., et al., Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma. Clin Exp Allergy, 2003. 33(1): p. 78-83.

120. Hakansson, A., et al., Investigation of genes coding for inflammatory components in Parkinson's disease. Mov Disord, 2005. 20(5): p. 569-73.

121. Fernandez, L., et al., Interleukin-10 polymorphisms in Spanish patients with IBD. Inflamm Bowel Dis, 2005. 11(8): p. 739-43.

122. Bantis, C., et al., Association of interleukin-10 gene G-1082A polymorphism with the progression of primary glomerulonephritis. Kidney Int, 2004. 66(1): p. 288-94.

123. Flanagan, S.E., et al., Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes, 2007. 56(7): p. 1930-7.

124. Stancakova, A., et al., Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men. Diabetes, 2009. 58(9): p. 2129-36.

125. Tabara, Y., et al., Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes, 2009. 58(2): p. 493-8.

126. van Dam, R.M., et al., Common variants in the ATP-sensitive K+ channel genes KCNJ11 (Kir6.2) and ABCC8 (SUR1) in relation to glucose intolerance: population-based studies and meta-analyses. Diabet Med, 2005. 22(5): p. 590-8.

127. Yokoi, N., et al., Association studies of variants in the genes involved in pancreatic beta-cell function in type 2 diabetes in Japanese subjects. Diabetes, 2006. 55(8): p. 2379-86.

128. Zhou, D., et al., The E23K variation in the KCNJ11 gene is associated with type 2 diabetes in Chinese and East Asian population. J Hum Genet, 2009. 54(7): p. 433-5.

129. Reyes, S., et al., K(ATP) channel Kir6.2 E23K variant overrepresented in human heart failure is associated with impaired exercise stress response. Hum Genet, 2009.

130. Lyssenko, V., et al., Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest, 2007. 117(8): p. 2155-63.

131. Pilgaard, K., et al., The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia, 2009.

132. Helgason, A., et al., Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet, 2007. 39(2): p. 218-25.

133. Tong, Y., et al., Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet, 2009. 10: p. 15.

134. Florez, J.C., et al., TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med, 2006. 355(3): p. 241-50.

135. Romagnani, S., Human TH1 and TH2 subsets: doubt no more. Immunol Today, 1991. 12(8): p. 256-7.

136. Zhu, S., et al., Polymorphisms of the IL-4, TNF-alpha, and Fcepsilon RIbeta genes and the risk of allergic disorders in at-risk infants. Am J Respir Crit Care Med, 2000. 161(5): p. 1655-9.

137. Li, Y., et al., Association between C-589T polymorphisms of interleukin-4 gene promoter and asthma: a meta-analysis. Respir Med, 2008. 102(7): p. 984-92.

138. Sandford, A.J., et al., Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity. J Allergy Clin Immunol, 2000. 106(1 Pt 1): p. 135-40.